These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells. Altevogt P, Apt D. Cancer Res; 1988 Mar 01; 48(5):1137-42. PubMed ID: 3342395 [Abstract] [Full Text] [Related]
3. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes. Li M, Muller J, Xu F, Hearing VJ, Gorelik E. Cancer Res; 1996 Oct 01; 56(19):4464-74. PubMed ID: 8813142 [Abstract] [Full Text] [Related]
4. Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine. Altevogt P. Cancer Res; 1986 Jun 01; 46(6):2912-6. PubMed ID: 2421887 [Abstract] [Full Text] [Related]
5. Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor. Grohmann U, Puccetti P, Belladonna ML, Fallarino F, Bianchi R, Binaglia L, Sagakuchi K, Mage MG, Appella E, Fioretti MC. J Immunol; 1995 May 01; 154(9):4630-41. PubMed ID: 7722315 [Abstract] [Full Text] [Related]
6. Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens. Altevogt P, von Hoegen P, Leidig S, Schirrmacher V. Cancer Res; 1985 Sep 01; 45(9):4270-7. PubMed ID: 4028013 [Abstract] [Full Text] [Related]
7. Enhancement of N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA amplification in a Simian virus 40-transformed Chinese hamster cell line by 3-aminobenzamide. Bürkle A, Meyer T, Hilz H, zur Hausen H. Cancer Res; 1987 Jul 15; 47(14):3632-6. PubMed ID: 3036344 [Abstract] [Full Text] [Related]
8. Kinetics of induction of DNA damage and lacZ gene mutations in stomach mucosa of mice treated with beta-propiolactone and N-methyl-N'-nitro-N-nitrosoguanidine, using single-cell gel electrophoresis and MutaMouse models. Brault D, Renault D, Tombolan F, Thybaud V. Environ Mol Mutagen; 1999 Jul 15; 34(2-3):182-9. PubMed ID: 10529742 [Abstract] [Full Text] [Related]
9. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Michelin S, Daya-Grosjean L, Sureau F, Saïd S, Sarasin A, Suárez HG. Oncogene; 1993 Jul 15; 8(7):1983-91. PubMed ID: 8510940 [Abstract] [Full Text] [Related]
10. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Umar A, Koi M, Risinger JI, Glaab WE, Tindall KR, Kolodner RD, Boland CR, Barrett JC, Kunkel TA. Cancer Res; 1997 Sep 15; 57(18):3949-55. PubMed ID: 9307278 [Abstract] [Full Text] [Related]
11. Inhibition of carcinogen-inducible DNA amplification in a simian virus 40-transformed hamster cell line by ethacridine or ethanol. Bürkle A. Cancer Res; 1989 May 15; 49(10):2584-7. PubMed ID: 2540904 [Abstract] [Full Text] [Related]
12. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene. Storer RD, Stein RB, Sina JF, DeLuca JG, Allen HL, Bradley MO. Cancer Res; 1986 Mar 15; 46(3):1458-64. PubMed ID: 3510726 [Abstract] [Full Text] [Related]
13. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. Manjunath R, Graziano RF, Green WR. J Immunol; 1986 Mar 15; 136(6):2271-9. PubMed ID: 3005407 [Abstract] [Full Text] [Related]
14. Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. Grohmann U, Belladonna ML, Allegrucci M, Silla S, Schiaffella E, Fioretti MC, Puccetti P. Viral Immunol; 1994 Mar 15; 7(4):155-67. PubMed ID: 7576030 [Abstract] [Full Text] [Related]
15. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement. Radinsky R, Kraemer PM, Proffitt MR, Culp LA. Cancer Res; 1988 Sep 01; 48(17):4941-53. PubMed ID: 3409227 [Abstract] [Full Text] [Related]
16. Anti-tumor immunity against CT26 colon tumor in mice immunized with plasmid DNA encoding beta-galactosidase fused to an envelope protein of endogenous retrovirus. Takeda J, Sato Y, Kiyosawa H, Mori T, Yokoya S, Irisawa A, Miyata M, Obara K, Fujita T, Suzuki T, Kasukawa R, Wanaka A. Cell Immunol; 2000 Aug 25; 204(1):11-8. PubMed ID: 11006013 [Abstract] [Full Text] [Related]
17. Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells. Wang S, Nishigori C, Miyakoshi J, Tsukada T, Shung B, Yagi T, Takebe H. Oncogene; 1993 Apr 25; 8(4):1009-16. PubMed ID: 8455928 [Abstract] [Full Text] [Related]
18. DNA repair and sensitivity of mouse embryo fibroblasts to methyl methanesulphonate and N-methyl-N'-nitro-N-nitrosoguanidine. Anuszewska E, Koziorowska J. Acta Biochim Pol; 1985 Apr 25; 32(4):295-304. PubMed ID: 3832702 [Abstract] [Full Text] [Related]
19. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Hotta H, Ross AH, Huebner K, Isobe M, Wendeborn S, Chao MV, Ricciardi RP, Tsujimoto Y, Croce CM, Koprowski H. Cancer Res; 1988 Jun 01; 48(11):2955-62. PubMed ID: 3365686 [Abstract] [Full Text] [Related]